These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 4303791

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro responses of aldosterone-producing adenomas to angiotensin II and ACTH after treatment with spironolactone before adrenalectomy.
    Wisgerhof M.
    J Lab Clin Med; 1984 Aug; 104(2):160-5. PubMed ID: 6086794
    [Abstract] [Full Text] [Related]

  • 3. The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism.
    Wisgerhof M, Brown RD, Hogan MJ, Carpenter PC, Edis AJ.
    J Clin Endocrinol Metab; 1981 Feb; 52(2):195-8. PubMed ID: 7462385
    [Abstract] [Full Text] [Related]

  • 4. Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration.
    Ganguly A, Luetscher JA, Weinberger MH.
    Clin Exp Hypertens A; 1982 Feb; 4(9-10):1695-714. PubMed ID: 6291813
    [Abstract] [Full Text] [Related]

  • 5. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.
    Carey RM, Ayers CR, Vaughan ED, Peach MJ, Herf SM.
    J Clin Invest; 1979 Apr; 63(4):718-26. PubMed ID: 438332
    [Abstract] [Full Text] [Related]

  • 6. Primary aldosteronism.
    Gordon RD.
    J Endocrinol Invest; 1995 Apr; 18(7):495-511. PubMed ID: 9221268
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
    Kater CE, Biglieri EG, Rost CR, Schambelan M, Hirai J, Chang BC, Brust N.
    J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
    [Abstract] [Full Text] [Related]

  • 9. Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.
    Vetter H, Vetter W.
    Klin Wochenschr; 1975 Apr 15; 53(8):391-3. PubMed ID: 211313
    [Abstract] [Full Text] [Related]

  • 10. New diagnostic procedure for primary aldosteronism: adrenal venous sampling under adrenocorticotropic hormone and angiotensin II receptor blocker--application to a case of bilateral multiple adrenal microadenomas.
    Yamahara K, Itoh H, Yamamoto A, Sasano H, Masatsugu K, Sawada N, Fukunaga Y, Sakaguchi S, Sone M, Yurugi T, Nakao K.
    Hypertens Res; 2002 Mar 15; 25(2):145-52. PubMed ID: 12047027
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aldosterone-producing adenomas responsive to angiotensin pose problems in diagnosis.
    Gordon RD, Hamlet SM, Tunny TJ, Klemm SA.
    Clin Exp Pharmacol Physiol; 1987 Mar 15; 14(3):175-9. PubMed ID: 2822305
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a test using saralasin to differentiate primary aldosteronism due to an aldosterone-producing adenoma from idiopathic hyperaldosteronism.
    Brown RD, Kem DC, Hogan MJ, Hegstad RL.
    Metabolism; 1984 Aug 15; 33(8):734-8. PubMed ID: 6748946
    [Abstract] [Full Text] [Related]

  • 14. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism.
    Kem DC, Weinberger MH, Gomez-Sanchez C, Higgins JR, Kramer NJ.
    J Lab Clin Med; 1976 Aug 15; 88(2):261-70. PubMed ID: 182890
    [Abstract] [Full Text] [Related]

  • 15. Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation.
    Rossi GP, Pitter G, Bernante P, Motta R, Feltrin G, Miotto D.
    J Hypertens; 2008 May 15; 26(5):989-97. PubMed ID: 18398342
    [Abstract] [Full Text] [Related]

  • 16. Use of the saline infusion test to diagnose the cause of primary aldosteronism.
    Arteaga E, Klein R, Biglieri EG.
    Am J Med; 1985 Dec 15; 79(6):722-8. PubMed ID: 3907346
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension.
    Gordon RD, Gomez-Sanchez CE, Hamlet SM, Tunny TJ, Klemm SA.
    J Hypertens Suppl; 1987 Dec 15; 5(5):S103-6. PubMed ID: 2832571
    [Abstract] [Full Text] [Related]

  • 18. Responses of aldosterone-producing adenomas to ACTH and angiotensins.
    Saruta T, Okuno T, Eguchi T, Nakamura R, Saito I, Kondo K, Oka M, Matsuki S.
    Acta Endocrinol (Copenh); 1979 Dec 15; 92(4):702-9. PubMed ID: 231371
    [Abstract] [Full Text] [Related]

  • 19. Regulation of aldosterone secretion in primary aldosteronism.
    Vetter H, Vetter W.
    Horm Metab Res; 1975 Sep 15; 7(5):418-24. PubMed ID: 1183923
    [Abstract] [Full Text] [Related]

  • 20. Effect of the serotonin 5-HT4 receptor agonist cisapride on aldosterone secretion in corticotropic insufficiency and primary hyperaldosteronism.
    Lefebvre H, Dhib M, Godin M, Contesse V, Delarue C, Rieu M, Wolf LM, Vaudry H, Kuhn JM.
    Neuroendocrinology; 1997 Sep 15; 66(3):229-33. PubMed ID: 9380281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.